All posts by: Michael Zand

About Michael Zand

CRISPR Therapeutics CEO discounts concerns raised in an unpublished paper – The Boston Globe

Continue reading

2018-01-09 NEWS

CRISPR Therapeutics CEO discounts concerns raised in an unpublished paper
The Boston Globe
SAN FRANCISCO — The new head of a genome editing company whose main research lab is in Cambridge on Tuesday brushed aside an unpublished paper that raised concerns about preexisting immune responses to the biotech’s gene-editing technology, known as

Continue reading

2018-01-09 NEWS

Sandbox News

CART Cell Therapy’s Effect on Blood Cancers
Sandbox News
CART cell therapy is developed through the modification of T-cells. The T-cells are specifically developed to “express a chimeric antigen receptor” (CAR-T). CAR-T therapy is generally used for blood cancers such as “non-Hodgkin’s lymphomas, some
Deep sea creatures provide a guiding light in the quest to develop cancer therapiesScience Daily

all 2 news articles »